Active RFAs at NIH (December 7, 2017)
| Doc Num | Link | Title | Activity Codes | Sponsor | Expiration Date |
| RFA-DA-18-019 | Link | NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional) | DP1 | NIDA | 08-15-2020 |
| RFA-DK-17-011 | Link | Catalyst Award in Diabetes, Endocrinology and Metabolic Diseases (DP1- Clinical Trial Not Allowed) | DP1 | NIDDK | 02-03-2018 |
| RFA-DA-18-004 | Link | Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) | DP2 | NIDA | 11-14-2019 |
| RFA-MH-18-510 | Link | BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | F32 | NIMH | 04-08-2020 |
| RFA-NS-18-007 | Link | NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00) | F99/K00 | NINDS | 12-14-2017 |
| RFA-HL-18-006 | Link | NHLBI Research Career Development Program in HIV-Related Heart, Lung, Blood and Sleep Research (K12) | K12 | NHLBI | 12-15-2017 |
| RFA-RM-17-010 | Link | Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2) | OT2 | Roadmap | 03-29-2019 |
| RFA-RM-15-018 | Link | Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) | OT2 | Roadmap | 06-15-2018 |
| RFA-NS-18-002 | Link | NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50) | P50 | NINDS | 12-16-2017 |
| RFA-HL-19-011 | Link | Shedding light on the dark genome: Long Non-coding RNA in Cardiovascular, Lung, Blood, and Sleep Research (R01 - Clinical Trial Not Allowed) | R01 | NHLBI | 03-31-2018 |
| RFA-HL-18-004 | Link | Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01) | R01 | NHLBI | 12-16-2017 |
| RFA-AG-18-023 | Link | Pathogenesis of Age-Related HIV Neurodegeneration (R01 Clinical Trial Not Allowed) | R01 | NIA | 02-10-2018 |
| RFA-AG-18-020 | Link | Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) | R01 | NIA | 02-10-2018 |
| RFA-AG-18-021 | Link | Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) | R01 | NIA | 02-22-2018 |
| RFA-EB-17-005 | Link | BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) | R01 | NIBIB | 10-18-2019 |
| RFA-EB-17-003 | Link | BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed) | R01 | NIBIB | 12-12-2018 |
| RFA-HD-18-036 | Link | Opioid Use Disorder in Pregnancy (R01) | R01 | NICHD | 12-14-2017 |
| RFA-DA-18-002 | Link | Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01) | R01 | NIDA | 08-23-2019 |
| RFA-DA-18-018 | Link | BRAIN Initiative: Tools to target, identify and characterize non-neuronal cells in the brain (R01 Clinical Trial Not Allowed) | R01 | NIDA | 10-05-2018 |
| RFA-DA-18-014 | Link | Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01) | R01 | NIDA | 12-15-2017 |
| RFA-DA-18-015 | Link | HIV-associated neuropathic pain and opioid interaction (R01) | R01 | NIDA | 12-19-2017 |
| RFA-ES-17-009 | Link | Population-Based Model Organism Research for G x E Exploration in Complex Disease Outcomes (R01 Clinical Trial Not Allowed) | R01 | NIEHS | 02-02-2018 |
| RFA-MH-18-610 | Link | Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed | R01 | NIMH | 01-09-2018 |
| RFA-MH-18-200 | Link | NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01) | R01 | NIMH | 06-21-2019 |
| RFA-MH-18-707 | Link | Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01- Clinical Trial Required) | R01 | NIMH | 10-16-2018 |
| RFA-MH-18-701 | Link | Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01- Clinical Trial Required) | R01 | NIMH | 10-16-2018 |
| RFA-MH-18-700 | Link | Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01-Clinical Trial Required) | R01 | NIMH | 10-16-2018 |
| RFA-MH-18-505 | Link | BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01) | R01 | NIMH | 11-14-2018 |
| RFA-NS-18-009 | Link | BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 - Clinical Trial Not Allowed) | R01 | NINDS | 03-16-2018 |
| RFA-NS-18-004 | Link | Human Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to CNS Small Blood and Lymphatic Vessels (R01) | R01 | NINDS | 12-12-2017 |
| RFA-NS-18-003 | Link | Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels (R01) | R01 | NINDS | 12-12-2017 |
| RFA-HL-17-015 | Link | Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21) | R21 | NHLBI | 09-08-2018 |
| RFA-MH-18-611 | Link | Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed) | R21 | NIMH | 01-09-2018 |
| RFA-AT-18-002 | Link | Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33) | R21/R33 | NCCIH | 01-19-2018 |
| RFA-MH-18-600 | Link | NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed) | R21/R33 | NIMH | 01-23-2018 |
| RFA-NS-16-013 | Link | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33) | R21/R33 | NINDS | 05-08-2018 |
| RFA-AG-18-024 | Link | Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed) | R24 | NIA | 02-23-2018 |
| RFA-NS-18-006 | Link | High Impact Neuroscience Research Resource Grants (R24) | R24 | NINDS | 02-10-2018 |
| RFA-MH-18-705 | Link | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33- Clinical Trial Required) | R33 | NIMH | 10-16-2018 |
| RFA-MH-18-703 | Link | Early Stage Testing of Pharmacologic or Device -based Interventions for the Treatment of Mental Health Disorders (R33- Clinical Trial Required) | R33 | NIMH | 10-16-2018 |
| RFA-MH-18-706 | Link | Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required) | R34 | NIMH | 10-16-2018 |
| RFA-NS-18-017 | Link | Planning Grant to Develop Phase III Clinical Trials for Lewy Body Dementia (R34 clinical Trial Not Allowed) | R34 | NINDS | 03-21-2018 |
| RFA-ES-17-008 | Link | Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Screening (R43) | R43/R44 | NIEHS | 01-13-2018 |
| RFA-DA-18-016 | Link | Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33) | R61/R33 | NIDA | 12-14-2017 |
| RFA-MH-18-704 | Link | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required) | R61/R33 | NIMH | 10-16-2018 |
| RFA-MH-18-702 | Link | Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required) | R61/R33 | NIMH | 10-16-2018 |
| RFA-AG-18-018 | Link | Development of Valid Reliable Markers of Aging-Related Biologic Mechanisms for Human Studies (U01) | U01 | NIA | 01-31-2018 |
| RFA-AG-18-013 | Link | Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional) | U01 | NIA | 02-21-2018 |
| RFA-AG-18-019 | Link | Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) | U01 | NIA | 02-22-2018 |
| RFA-EB-17-004 | Link | BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed) | U01 | NIBIB | 12-12-2018 |
| RFA-NS-18-010 | Link | BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01) | U01 | NINDS | 01-20-2018 |
| RFA-NS-18-008 | Link | BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01) | U01 | NINDS | 12-16-2017 |
| RFA-EY-17-003 | Link | NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed) | U24 | NEI | 02-22-2018 |
| RFA-AG-18-014 | Link | Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed) | U24 | NIA | 02-21-2018 |
| RFA-NS-18-005 | Link | BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24) | U24 | NINDS | 02-10-2018 |
| RFA-NS-18-012 | Link | Translational Neural Devices (U44 - Clinical Trial Required) | U44 | NINDS | 10-22-2020 |
| RFA-NS-18-001 | Link | Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54) | U54 | NINDS | 01-17-2018 |
| RFA-DA-18-020 | Link | NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional) | UG3/UH3 | NIDA | 09-08-2020 |
| RFA-NS-18-011 | Link | Translational Neural Devices (UG3/UH3 - Clinical Trial Required) | UG3/UH3 | NINDS | 10-22-2020 |
Simons Foundation Autism Research Initiative (SFARI)
SFARI Explorer Awards: This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.
The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.
Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.
Applications are considered on a rolling basis, with a response time as early as 30 days.
National MS Society Pilot Grant Projects
The Society funds high-risk pilot grants to quickly test novel ideas. Funding is provided for one year to test innovative, cutting-edge ideas or untested methods, and to gather sufficient preliminary data to apply for longer-term funding. We welcome applications for studies related to multiple sclerosis that may serve to advance our mission of stopping MS progression, restoring function and improving quality of life, and preventing MS. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation.
Pilot research grants:Researchers who have completed their post-doctoral training are invited to apply. Individuals who are currently postdoctoral fellows or the equivalent, or who are graduate/medical students are not eligible for support under this program. In order to submit a proposal for research support, investigators must first register with our Apply Online site (https://nmss.fluxx.io/) and complete a pre-application. Staff will review the pre-application to determine whether the research plan is appropriate and relevant to our goals. NOTE: As of June 10, 2011, we will no longer accept pilot grant applications using the old application forms. All pilot applications must be submitted through the online application site (https://nmss.fluxx.io/).
Deadlines: New applications reviewed on a quarterly basis, with 2017 deadlines of January 4, April 5, July 12, October 4.
Download complete information on applying for pilot research grants (.pdf)
For more information, please contact: Elisabeth Mari, PhD
Elisabeth.Mari@nmss.org